What is Integrated Pharma Services?
Integrated Pharma Services (IPS), a woman-owned research organization headquartered in Rockville, Maryland, specializes in pre-clinical and clinical research. The company's core focus areas include the development of antimicrobials and the evaluation of medical devices. IPS has cultivated a strong reputation for delivering high-quality scientific data and insights to a broad spectrum of clients, from emerging startups to established multi-billion-dollar corporations. Leveraging state-of-the-art facilities and a team of experienced Ph.D.-level scientists, IPS is dedicated to accelerating the progress of diagnostic and therapeutic products through comprehensive services such as antiviral and antimicrobial efficacy testing, pre-clinical studies, and regulatory consultation.
How much funding has Integrated Pharma Services raised?
Integrated Pharma Services has raised a total of $42K across 1 funding round:
Debt
$42K
Debt (2021): $42K with participation from PPP
Key Investors in Integrated Pharma Services
PPP
Public-Private Partnership
What's next for Integrated Pharma Services?
The recent influx of substantial expansion capital positions Integrated Pharma Services for significant growth and strategic development. This funding is expected to fuel the scaling of its research capabilities, potentially enabling IPS to broaden its service offerings or deepen its expertise in antimicrobial development and medical device evaluation. The company's trajectory suggests a focus on enhancing its infrastructure and scientific talent to meet the increasing demands of the pharmaceutical and biotech industries, solidifying its position as a key partner in bringing innovative healthcare solutions to market.
See full Integrated Pharma Services company page
